Mobocertinib Active Not Recruiting Phase 1 Trials for Non-Small Cell Lung Cancer (NSCLC) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03807778A Study of Mobocertinib in Japanese Adults With Non-Small Cell Lung Cancer